Regulatory Aspects of Nanomedicine in Europe

Nanomedicine offers numerous improvements to medical diagnosis, drug delivery, therapy and implants. The potential impact of nanomedicine is foreseen to radically change health care; however it is also challenging existing perceptions, dynamics and standards relating to ethics, safety and regulation. There have been increasing calls for governments and other stakeholders to evaluate the adequacy of current health and safety regimes to effectively regulate current and anticipated applications. This chapter hence proceeds to detail the regulatory framework and regulatory bodies in the European Union involved in the regulation of nanomedicine